Literature DB >> 20214108

The fixed-cost dilemma: what counts when counting cost-reduction efforts?

Stephen S Rauh1, Eric Wadsworth, William B Weeks.   

Abstract

The high fixed-cost structure of hospitals and the predominance of "joint costs" mean few truly variable costs can be captured by small or incremental cost reduction strategies. Many of the proxy metrics used to measure cost savings, such as length of stay and readmissions, typically does not reflect true cost savings, but should be seen as measures of additional capacity with the potential for added revenue. To achieve true savings, hospitals should consider reducing capacity when possible and making better use of the remaining capacity, increasing throughput, and reducing costs per discharge.

Mesh:

Year:  2010        PMID: 20214108

Source DB:  PubMed          Journal:  Healthc Financ Manage        ISSN: 0735-0732


  4 in total

1.  End-of-life care in the intensive care unit: can we simultaneously increase quality and reduce costs?

Authors:  J Randall Curtis; Ruth A Engelberg; Mark E Bensink; Scott D Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2012-08-02       Impact factor: 21.405

2.  An exploratory analysis of transfer times in a rural trauma system.

Authors:  James M Whedon; Friedrich M von Recklinghausen
Journal:  J Emerg Trauma Shock       Date:  2013-10

Review 3.  Financial evaluations of antibiotic stewardship programs-a systematic review.

Authors:  Jan-Willem H Dik; Pepijn Vemer; Alex W Friedrich; Ron Hendrix; Jerome R Lo-Ten-Foe; Bhanu Sinha; Maarten J Postma
Journal:  Front Microbiol       Date:  2015-04-16       Impact factor: 5.640

Review 4.  Highlighting the gaps in quantifying the economic burden of surgical site infections associated with antimicrobial-resistant bacteria.

Authors:  Katia Iskandar; Massimo Sartelli; Marwan Tabbal; Luca Ansaloni; Gian Luca Baiocchi; Fausto Catena; Federico Coccolini; Mainul Haque; Francesco Maria Labricciosa; Ayad Moghabghab; Leonardo Pagani; Pierre Abi Hanna; Christine Roques; Pascale Salameh; Laurent Molinier
Journal:  World J Emerg Surg       Date:  2019-11-21       Impact factor: 5.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.